GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MoonLake Immunotherapeutics (MLTX) | 8/10/2026 7:53:48 AM | Small | View | Financials | 10-Q | SEC | 2Q 2026 ending: 6/30/2026 | Assets $573,947,000 | EPS -$0.84 | ||
| MoonLake Immunotherapeutics (MLTX) | 8/10/2026 7:17:16 AM | View | Financials | Earnings | SEC | 2Q 2026 | Assets $573,947,000 | EPS -$0.84 | Export Earnings Model | ||
| MoonLake Immunotherapeutics (MLTX) | 5/11/2026 9:01:15 AM | Small | View | Financials | 10-Q | SEC | 1Q 2026 ending: 3/31/2026 | Assets $400,374,000 | EPS -$0.98 | ||
| MoonLake Immunotherapeutics (MLTX) | 5/11/2026 7:10:08 AM | View | Financials | Earnings | SEC | 1Q 2026 | Assets $400,374,000 | EPS -$0.98 | Export Earnings Model | ||
| MoonLake Immunotherapeutics (MLTX) | 4/21/2026 4:41:22 PM | View | Proxy | SEC | Y 2025 | ||||||
| MoonLake Immunotherapeutics (MLTX) | 2/25/2026 6:25:50 AM | Small | View | Financials | 10-K | SEC | Y 2025 ending: 12/31/2025 | Assets $424,433,000 | EPS -$3.53 | ||
| MoonLake Immunotherapeutics (MLTX) | 11/5/2025 7:12:11 AM | Small | View | Financials | 10-Q | SEC | 3Q 2025 ending: 9/30/2025 | Assets $414,335,000 | EPS -$1.10 | ||
| MoonLake Immunotherapeutics (MLTX) | 11/5/2025 7:02:37 AM | View | Financials | Earnings | SEC | 3Q 2025 | Assets $414,335,000 | EPS -$1.10 | Export Earnings Model | ||
| MoonLake Immunotherapeutics (MLTX) | 8/5/2025 7:12:44 AM | Small | View | Financials | 10-Q | SEC | 2Q 2025 ending: 6/30/2025 | Assets $460,096,000 | EPS -$0.87 | ||
| MoonLake Immunotherapeutics (MLTX) | 8/5/2025 7:02:23 AM | View | Financials | Earnings | SEC | 2Q 2025 | Assets $460,096,000 | EPS -$0.87 | Export Earnings Model | ||
| MoonLake Immunotherapeutics (MLTX) | 5/12/2025 4:13:28 PM | Small | View | Financials | 10-Q | SEC | 1Q 2025 ending: 3/31/2025 | Assets $511,262,000 | EPS -$0.63 | ||
| MoonLake Immunotherapeutics (MLTX) | 5/12/2025 4:03:30 PM | View | Financials | Earnings | SEC | 1Q 2025 | Assets $511,262,000 | EPS -$0.63 | Export Earnings Model | ||
| MoonLake Immunotherapeutics (MLTX) | 4/22/2025 4:34:56 PM | View | Proxy | SEC | Y 2024 | ||||||
| MoonLake Immunotherapeutics (MLTX) | 2/26/2025 7:22:38 AM | Small | View | Financials | 10-K | SEC | Y 2024 ending: 12/31/2024 | Assets $477,933,282 | EPS -$1.89 | ||
| MoonLake Immunotherapeutics (MLTX) | 2/26/2025 7:09:38 AM | View | Financials | Earnings | SEC | Y 2024 | Assets $477,933,282 | EPS -$0.72 | Export Earnings Model | ||
| MoonLake Immunotherapeutics (MLTX) | 11/7/2024 7:21:01 AM | Small | View | Financials | 10-Q | SEC | 3Q 2024 ending: 9/30/2024 | Assets $518,213,328 | EPS -$0.56 | ||
| MoonLake Immunotherapeutics (MLTX) | 11/7/2024 7:05:58 AM | View | Financials | Earnings | SEC | 3Q 2024 | Assets $518,213,328 | EPS -$0.56 | Export Earnings Model | ||
| MoonLake Immunotherapeutics (MLTX) | 8/7/2024 8:17:38 AM | Small | View | Financials | 10-Q | SEC | 2Q 2024 ending: 6/30/2024 | Assets $544,877,690 | EPS -$0.39 | ||
| MoonLake Immunotherapeutics (MLTX) | 8/7/2024 8:03:03 AM | View | Financials | Earnings | SEC | 2Q 2024 | Assets $544,877,690 | EPS -$0.39 | Export Earnings Model | ||
| MoonLake Immunotherapeutics (MLTX) | 5/7/2024 8:18:10 AM | Small | View | Financials | 10-Q | SEC | 1Q 2024 ending: 3/31/2024 | Assets $564,117,138 | EPS -$0.22 | ||
| MoonLake Immunotherapeutics (MLTX) | 5/7/2024 8:08:09 AM | Small | View | Financials | 10-K/A | SEC | Y 2023 ending: 12/31/2023 | Assets $526,540,115 | EPS -$0.73 | ||
| MoonLake Immunotherapeutics (MLTX) | 5/7/2024 8:02:53 AM | View | Financials | Earnings | SEC | 1Q 2024 | Assets $564,117,138 | EPS -$0.22 | Export Earnings Model | ||
| MoonLake Immunotherapeutics (MLTX) | 4/24/2024 4:37:52 PM | View | Proxy | SEC | Y 2023 | ||||||
| MoonLake Immunotherapeutics (MLTX) | 2/29/2024 8:15:10 AM | Small | View | Financials | 10-K | SEC | Y 2023 ending: 12/31/2023 | Assets $526,540,115 | EPS -$0.73 | ||
| MoonLake Immunotherapeutics (MLTX) | 2/29/2024 8:05:51 AM | View | Financials | Earnings | SEC | Y 2023 | Assets $526,540,115 | EPS -$0.10 | Export Earnings Model | ||
| MoonLake Immunotherapeutics (MLTX) | 11/14/2023 11:31:28 AM | View | Financials | Earnings | SEC | 3Q 2023 | Assets $500,218,686 | EPS -$0.18 | Export Earnings Model | ||
| MoonLake Immunotherapeutics (MLTX) | 11/14/2023 8:16:14 AM | Small | View | Financials | 10-Q | SEC | 3Q 2023 ending: 9/30/2023 | Assets $500,218,686 | EPS -$0.18 | ||
| MoonLake Immunotherapeutics (MLTX) | 8/10/2023 8:24:49 AM | Small | View | Financials | 10-Q | SEC | 2Q 2023 ending: 6/30/2023 | Assets $506,621,195 | EPS -$0.23 | ||
| MoonLake Immunotherapeutics (MLTX) | 8/10/2023 8:16:53 AM | View | Financials | Earnings | SEC | 2Q 2023 | Assets $506,621,195 | EPS -$0.23 | Export Earnings Model | ||
| MoonLake Immunotherapeutics (MLTX) | 5/12/2023 7:46:59 AM | View | Financials | Earnings | WIRE | 1Q 2023 | Assets $66,796,819 | EPS -$0.23 | Export Earnings Model | ||
| MoonLake Immunotherapeutics (MLTX) | 5/11/2023 4:12:23 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2023 ending: 3/31/2023 | Assets $66,796,819 | EPS -$0.23 | ||
| MoonLake Immunotherapeutics (MLTX) | 4/26/2023 4:42:08 PM | View | Proxy | SEC | Y 2022 | ||||||
| MoonLake Immunotherapeutics (MLTX) | 3/20/2023 8:59:34 AM | Micro | View | Financials | 10-K | SEC | Y 2022 ending: 12/31/2022 | Assets $76,843,301 | EPS -$1.70 | ||
| MoonLake Immunotherapeutics (MLTX) | 3/20/2023 7:46:18 AM | View | Financials | Earnings | SEC | Y 2022 | Assets $76,843,301 | EPS -$0.43 | Export Earnings Model | ||
| MoonLake Immunotherapeutics (MLTX) | 11/14/2022 8:07:56 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2022 ending: 9/30/2022 | Assets $88,591,864 | EPS -$0.27 | ||
| MoonLake Immunotherapeutics (MLTX) | 11/14/2022 8:01:23 AM | View | Financials | Earnings | WIRE | 3Q 2022 | Assets $88,591,864 | EPS -$0.27 | Export Earnings Model | ||
| MoonLake Immunotherapeutics (MLTX) | 8/12/2022 4:21:48 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2022 ending: 6/30/2022 | Assets $98,433,652 | EPS -$0.34 | ||
| MoonLake Immunotherapeutics (MLTX) | 5/16/2022 4:29:51 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2022 ending: 3/31/2022 | Assets $11,772,038 | EPS -$106.55 | ||
| Helix Acquisition Corp (MLTX) | 3/4/2022 4:11:07 PM | View | Proxy | SEC | Y 2021 | ||||||
| Helix Acquisition Corp (MLTX) | 2/17/2022 4:13:10 PM | Micro | View | Financials | 10-K | SEC | Y 2021 ending: 12/31/2021 | Assets $9,682,454 | EPS -$0.31 | ||
| Helix Acquisition Corp (MLTX) | 2/14/2022 6:22:08 AM | View | Proxy | SEC | Y 2021 | ||||||
| Helix Acquisition Corp (MLTX) | 12/14/2021 5:33:02 PM | Micro | View | Financials | 10-Q/A | SEC | 3Q 2021 ending: 9/30/2021 | Assets $116,247,146 | EPS -$2.63 | ||
| Helix Acquisition Corp (MLTX) | 12/14/2021 5:23:01 PM | Micro | View | Financials | 10-K/A | SEC | Y 2020 ending: 12/31/2020 | ||||
| Helix Acquisition Corp (MLTX) | 11/12/2021 4:16:01 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2021 ending: 9/30/2021 | Assets $116,247,146 | EPS -$2.63 | ||
| Helix Acquisition Corp (MLTX) | 8/16/2021 4:14:36 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2021 ending: 6/30/2021 | ||||
| Helix Acquisition Corp (MLTX) | 5/21/2021 4:24:15 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2021 ending: 3/31/2021 | ||||
| Helix Acquisition Corp (MLTX) | 3/31/2021 10:13:25 AM | Micro | View | Financials | 10-K | SEC | Y 2020 ending: 12/31/2020 | ||||
| Helix Acquisition Corp (MLTX) | 12/3/2020 4:43:37 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2020 ending: 9/30/2020 |